Approval · Notice of Compliance 9422 · 2008
ALIMTA: Notice of Compliance 9422
Issued March 13, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9422
- Date
- March 13, 2008
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 100mg/vial
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALIMTA | 02306433 | Cancelled Post Market |
Medicinal ingredients
- PEMETREXED DISODIUM 100 MG per VIAL